Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Operating income as a percentage of revenue
3Y CAGR
+36.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 11.40% | +205.7% |
| 2024 | -10.78% | -15.6% |
| 2023 | -9.32% | -310.0% |
| 2022 | 4.44% | +101.1% |
| 2021 | -406.38% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |